Comparison of Midregional Pro-Atrial Natriuretic Peptide With N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Survival in Patients With Chronic Heart Failure

Journal of the American College of Cardiology

Volumn 50, Issue 20, 2007, Pages 1973-1980

  von Haehling, Stephan ^a,b   Jankowska, Ewa A ^c   Morgenthaler, Nils G ^d   Vassanelli, Corrado ^e   Zanolla, Luisa ^e   Rozentryt, Piotr ^f   Filippatos, Gerasimos S ^g   Doehner, Wolfram ^a   Koehler, Friedrich ^a   Papassotiriou, Jana ^d   Kremastinos, Dimitrios T ^g   Banasiak, Waldemar ^c   Struck, Joachim ^d   Ponikowski, Piotr ^c   Bergmann, Andreas ^d   Anker, Stefan D ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MILITARY HOSPITAL   (Poland)

^d Research Department   (Germany)

^e UNIVERSITY OF VERONA   (Italy)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; VALIDATION STUDY;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE;

EID: 35748935092     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.08.012     Document Type: Article

References (23)

1. Jortani S.A., Prabhu S.D., and Valdes Jr. R. Strategies for developing biomarkers of heart failure. Clin Chem 50 (2004) 265-278
2. Cowie M.R., Jourdain P., Maisel A., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
3. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
4. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
5. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
6. Anand I.S., Fisher L.D., Chiang Y.T., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (VAL-HEFT). Circulation 107 (2003) 1278-1283
7. Cheng V., Kazanagra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37 (2001) 386-391
8. Troughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
9. Yoshibayashi M., Saito Y., and Nakao K. Brain natriuretic peptide versus atrial natriuretic peptide-physiological and pathophysiological significance in children and adults: a review. Eur J Endocrinol 135 (1996) 265-268
10. Potter L.R., Abbey-Hosch S., and Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27 (2006) 47-72
11. Ala-Kopsala M., Magga J., Peuhkurinen K., et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
12. Seidler T., Pemberton C., Yandle T., Espiner E., Nicholls G., and Richards M. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 255 (1999) 495-501
13. Morgenthaler N.G., Struck J., Thomas B., and Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50 (2004) 234-236
14. Swedberg K., Cleland J., Dargie H., et al., Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
15. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
16. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
17. Ala-Kopsala M., Magga J., Peuhkurinen K., Leipala J., Ruskoaho H., Leppaluoto J., and Vuolteenaho O. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
18. Gegenhuber A., Struck J., Poelz W., et al. Mid-regional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem 52 (2006) 827-831
19. McMurray J., and Pfeffer M.A. New therapeutic options in congestive heart failure: Part I. Circulation 105 (2002) 2099-2106
20. de Bold A.J., Bruneau B.G., and Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 31 (1996) 7-18
21. McGrath M.F., de Bold M.L., and de Bold A.J. The endocrine function of the heart. Trends Endocrinol Metab 16 (2005) 469-477
22. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 (2004) 505-513
23. von Haehling S., and Anker S.D. Future prospects of anticytokine therapy in chronic heart failure. Expert Opin Investig Drugs 14 (2005) 163-176